Anyone that is familiar with the history of kratom, knows and understands that it is often misunderstood, mistakenly thought of a highly addictive opioid and cause of death around the country warranting being classification as a Schedule I controlled substance.
Well, representation of kratom industry was at Capitol Hill Friday, including Kratom Trade Association(KTA) held a briefing today on Capitol Hill, along with experts representing the American Kratom Association, Botanical Education Alliance, Drug Policy Alliance, Plants People Health and A Leaf of Faith.
- Michael Werner, KTA Policy Advisor KTA (Kratom Trade Association), held two briefings today on Capitol Hill to clear up misinformation and make sure that policymakers know
- The Drug Enforcement Administration (DEA) unsuccessfully attempted to ban Kratom in 2016 when it inaccurately claimed it had “a high potential for abuse” and the U.S. Food and Drug Administration (FDA) routinely issues misleading statements about Kratom’s safety.
- The Kratom Trade Association (KTA) is dedicated to the safe and responsible use of Kratom botanical products in the U.S.
“We can balance consumer safety with access to this natural botanical product consumed by millions of Americans without government overreach,” said Michael Werner, a federal regulatory policy and legislative advisor for KTA. “Working with legislators, KTA seeks to find common-sense compromises based on science in the face of misinformation to protect people’s right to consume Kratom and manage their own well-being.”
Original Source: https://www.apnews.com/49255b8109a44e1bb011bc68a6ccd989